Patrizia Serra

1.9k total citations
51 papers, 1.0k citations indexed

About

Patrizia Serra is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Patrizia Serra has authored 51 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 17 papers in Cancer Research and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Patrizia Serra's work include Breast Cancer Treatment Studies (15 papers), HER2/EGFR in Cancer Research (12 papers) and Cancer Treatment and Pharmacology (11 papers). Patrizia Serra is often cited by papers focused on Breast Cancer Treatment Studies (15 papers), HER2/EGFR in Cancer Research (12 papers) and Cancer Treatment and Pharmacology (11 papers). Patrizia Serra collaborates with scholars based in Italy, Tanzania and United States. Patrizia Serra's co-authors include Dino Amadori, Toni Ibrahim, Laura Mercatali, Emanuela Scarpi, Oriana Nanni, D. Amadori, Emanuela Flamini, Andrea Rocca, Sara Bravaccini and Marco Maltoni and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Patrizia Serra

46 papers receiving 979 citations

Peers

Countries citing papers authored by Patrizia Serra

Since Specialization

Citations

This map shows the geographic impact of Patrizia Serra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrizia Serra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrizia Serra more than expected).

Fields of papers citing papers by Patrizia Serra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrizia Serra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrizia Serra. The network helps show where Patrizia Serra may publish in the future.

Co-authorship network of co-authors of Patrizia Serra

This figure shows the co-authorship network connecting the top 25 collaborators of Patrizia Serra. A scholar is included among the top collaborators of Patrizia Serra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrizia Serra. Patrizia Serra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preparation of a Micronutrient-Enriched Apricot Kernel Oil and Assessment of In Vitro Chemopreventive Properties 2025 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), Patrizia Serra, Giorgia Simonetti, (unknown), Alessio Porta, (unknown), Emanuela Martino, Simona Collina, Anna Tesei	0
2	Effect of low-dose tamoxifen on benign gynecological and breast conditions in a phase 3 trial in noninvasive breast cancer 2025 ·JNCI Journal of the National Cancer Institute ·Alessio Carbone, Martino Oliva, Matteo Puntoni, Aliana Guerrieri‐Gonzaga, (unknown), Matteo Lazzeroni, Davide Serrano, Livia Giordano, Maria Digennaro, Laura Cortesi, (unknown), Katia Cagossi, (unknown), Patrizia Serra, (unknown), Bernardo Bonanni, Andrea DeCensi	0
3	Use of the ONCO-TreC electronic diary compared with a standard paper diary to improve adherence to oral cancer therapy in patients with solid and haematological tumours: protocol for a randomised controlled trial 2022 ·BMJ Open ·Alessandro Passardi, Patrizia Serra, Orazio Caffo, Carla Masini, (unknown), Roberto Vespignani, Valeria Giardino, Elisabetta Petracci, (unknown), (unknown), Cecilia Anesi, Marco Dianti, Claudio Eccher, Enrico Maria Piras, Lorenzo Gios, Annalisa Campomori, Valentina Oberosler, Stefano Forti	1
4	Effects of yoga practice on physiological distress, fatigue and QOL in patients affected by breast cancer undergoing adjuvant radiotherapy 2022 ·Technical Innovations & Patient Support in Radiation Oncology ·(unknown), Patrizia Serra, Anna Tesei, (unknown), Chiara Arienti, (unknown), (unknown), Antonino Romeo, Giovanni Martinelli	8
5	Effects of a Diet Based on Foods from Symbiotic Agriculture on the Gut Microbiota of Subjects at Risk for Metabolic Syndrome 2021 ·Nutrients ·Silvia Turroni, Elisabetta Petracci, Valeria Edefonti, Anna Maria Giudetti, Federica D’Amico, (unknown), (unknown), Laura Del Coco, Francesco Paolo Fanizzi, Simone Rampelli, (unknown), Claudia Rengucci, Jenny Bulgarelli, Marcella Tazzari, Nicoletta Pellegrini, Monica Ferraroni, Oriana Nanni, Patrizia Serra	6
6	An Integrated Model to Improve Medication Reconciliation in Oncology: Prospective Interventional Study 2021 ·Journal of Medical Internet Research ·Alessandro Passardi, Patrizia Serra, Caterina Donati, (unknown), (unknown), Roberto Vespignani, (unknown), (unknown), Giovanni Martinelli, Oriana Nanni, Mattia Altini, Giovanni Luca Frassineti, (unknown)	1
7	LBA17 Overall survival (OS) results from the phase III MONALEESA-2 (ML-2) trial of postmenopausal patients (pts) with hormone receptor positive/human epidermal growth factor receptor 2 negative (HR+/HER2−) advanced breast cancer (ABC) treated with endocrine therapy (ET) ± ribociclib (RIB) 2021 ·Annals of Oncology ·G. N. Hortobágyi, Salomon M. Stemmer, H.A. Burris, Yoon Sim Yap, Gabe S. Sonke, L. Hart, M. Campone, Katarína Petráková, Eric P. Winer, W Janni, Pierfranco Conté, David Cameron, Fabrice André, CL Arteaga, Juan Pablo Zarate, A. Chakravartty, Tanya Taran, Fabienne Le Gac, Patrizia Serra, Joyce O’Shaughnessy	41
8	Early Detection and Investigation of Extracellular Vesicles Biomarkers in Breast Cancer 2021 ·Frontiers in Molecular Biosciences ·(unknown), Tania Rossi, Emanuela Scarpi, Giulia Gallerani, Ivan Vannini, Samanta Salvi, (unknown), (unknown), Sara Salucci, Michela Battistelli, Patrizia Serra, Roberta Maltoni, William C. Cho, Francesco� Fabbri	11
9	How Many Cancer Clinical Trials Can a Clinical Research Coordinator Manage? The Clinical Research Coordinator Workload Assessment Tool 2020 ·JCO Oncology Practice ·Francesca Fabbri, (unknown), Patrizia Serra, Bernadette Vertogen, Daniele Andreis, Monia Dall’Agata, (unknown), Valentina Gallá, Ilaria Massa, (unknown), Manuela Monti, (unknown), (unknown), Angela Ragazzini, (unknown), (unknown), Linda Valmorri, Chiara Zingaretti, F. Zumaglini, (unknown)	7
10	Are There Differences in Androgen Receptor Expression in Invasive Breast Cancer in African (Tanzanian) Population in Comparison With the Caucasian (Italian) Population? 2018 ·Frontiers in Endocrinology ·Sara Bravaccini, Sara Ravaioli, Dino Amadori, Emanuela Scarpi, Maurizio Puccetti, Andrea Rocca, Maria Maddalena Tumedei, Nestory Masalu, (unknown), (unknown), (unknown), Alberto Farolfi, Roberta Maltoni, Massimiliano Bonafè, Patrizia Serra, Giuseppe Bronte	14
11	Dried Blood and Serum Spots As A Useful Tool for Sample Storage to Evaluate Cancer Biomarkers 2018 ·Journal of Visualized Experiments ·Laura Mercatali, Patrizia Serra, Giacomo Miserocchi, Chiara Spadazzi, Chiara Liverani, Alessandro De Vita, Giorgia Marisi, Alberto Bongiovanni, Federica Recine, (unknown), Nestory Masalu, Toni Ibrahim, Dino Amadori	5
12	Setting up a community-based cervical screening service in a low-income country: a pilot study from north-western Tanzania 2017 ·International Journal of Public Health ·Nestory Masalu, Patrizia Serra, Dino Amadori, (unknown), Charles Riziki Majinge, (unknown), Oriana Nanni, Sara Bravaccini, Maurizio Puccetti, Rosario Tumino, Lauro Bucchi	7
13	The Mwanza Cancer Project 2016 ·The Lancet Oncology ·Dino Amadori, Patrizia Serra, Lauro Bucchi, Mattia Altini, Charles Riziki Majinge, (unknown), (unknown), Catherine John, Daniela Cristina Stefan, Nestory Masalu	22
14	RANKL: A promising circulating marker for bone metastasis response 2016 ·Oncology Letters ·Toni Ibrahim, Marianna Ricci, Emanuela Scarpi, Alberto Bongiovanni, (unknown), Nada Riva, Chiara Liverani, Alessandro De Vita, Federico La Manna, Devil Oboldi, Patrizia Serra, Flavia Foca, Lorenzo Cecconetto, Dino Amadori, Laura Mercatali	25
15	Triple negative breast cancer in a poor resource setting in North-Western Tanzania: a preliminary study of 52 patients 2014 ·BMC Research Notes ·Peter Rambau, Nestory Masalu, (unknown), (unknown), Patrizia Serra, Sara Bravaccini	16
16	Role of RANK, RANKL, OPG, and CXCR4 Tissue Markers in Predicting Bone Metastases in Breast Cancer Patients 2011 ·Clinical Breast Cancer ·Toni Ibrahim, (unknown), Michele Gaudio, Laura Mercatali, Emanuela Scarpi, Wainer Zoli, Patrizia Serra, (unknown), Luigi Serra, Yibin Kang, Dino Amadori	43
17	The Role of CXCR4 in the Prediction of Bone Metastases from Breast Cancer: A Pilot Study 2011 ·Oncology ·(unknown), Toni Ibrahim, Michele Gaudio, Laura Mercatali, Emanuela Scarpi, Wainer Zoli, Patrizia Serra, Sara Bravaccini, (unknown), Luigi Serra, Dino Amadori	18
18	Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1–3 node-positive rapidly proliferating breast cancer 2010 ·Breast Cancer Research and Treatment ·Dino Amadori, Rosella Silvestrini, Mario De Lena, Francesco Boccardo, Andrea Rocca, Emanuela Scarpi, Francesco Schittulli, Mario Brandi, Roberta Maltoni, Patrizia Serra, Riccardo Ponzone, Nicoletta Biglia, Lorenzo Gianni, A. Tienghi, Maria Rosaria Valerio, (unknown), Laura Amaducci, Marina Faedi, Editta Baldini, Angelo Paradiso	19
19	Pathogenesis of osteoblastic bone metastases from prostate cancer 2010 ·Cancer ·Toni Ibrahim, Emanuela Flamini, Laura Mercatali, (unknown), Patrizia Serra, Dino Amadori	143
20	Prospective use of tumor proliferative activity for adjuvant therapy in node-negative breast cancer patients 1997 ·Cell Proliferation ·D. Amadori, Annalisa Volpi, Oriana Nanni, M. Marangolo, Alessandra Ravaioli, P Pacini, (unknown), Angelo Gambi, Anna Rossi, S. Luzi Fedeli, Monica Indelli, D. Perrone, Donata Casadei Giunchi, Patrizia Serra, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact